While the goal is to restore normal regulation, there is a theoretical risk of pushing the immune system in an unintended direction
Optimal dosing, timing, route of administration, and duration of treatment for human bone healing have not been established for investigational peptides
GLP-1 (Glucagon-like Peptide-1) agonists, are typically used to treat type 2 diabetes and cases of obesity
Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants
Do I need an in-person visit to get started
Paolo Magni, Universit degli Studi di Milano, Italy Copyright 2013 Mquinion, Langlet, Zgheib, Dickson, Dehouck, Chauveau and Viltart